System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Epublish

PubMed: 42898421 DOI: 10.34172/bi.33703

Ethosomal drug delivery systems for skin cancer: Mechanistic insights, formulation strategies, and translational challenges.

Bioimpacts 16:33703

Authors: Bhupendra G Prajapati, Omar Awad Alsaidan, Sami I Alzarea, Kiran Dudhat, Chandrakantsing V Pardeshi, Namdev Dhas, Himanshu Paliwal, Biswajit Basu, Suhaskumar Patel, Dignesh Khunt

Affiliations

  • Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, 391760, Gujarat, India.
  • Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia.
  • Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Aljouf 72341, Saudi Arabia.
  • School of Pharmacy, RK University, Kasturbadham, Rajkot, Gujarat, 360020, India.
  • Department of Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur 425405, India.
  • Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka State, India.
  • Marwadi University Research Center, Faculty of Pharmacy, Marwadi University, Rajkot, 360003, Gujarat, India.
  • Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Kolkata, 700126, West Bengal, India.
  • Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India.
  • School of Pharmacy, Gujarat Technological University, Gandhinagar 382028, India.

Abstract

INTRODUCTION

Skin cancer is one of the most prevalent malignancies worldwide, with incidence increasing by approximately 2-3% annually due to prolonged ultraviolet radiation exposure, genetic predisposition, and an ageing population. Conventional treatments, including oral, injectable, and topical therapies, are often limited by poor skin permeability, first-pass metabolism, systemic toxicity, and inadequate tumor targeting.

METHODS

This review systematically examines ethosomal drug delivery systems, focusing on their composition, mechanism of skin permeation, and formulation strategies. Key aspects such as phospholipid composition, ethanol concentration (20-45% w/w), preparation techniques, and interaction with tumor-altered skin barriers are critically analyzed.

RESULTS

Ethosomes, as deformable lipid vesicles, enhance transdermal drug delivery by fluidizing stratum corneum lipid lamellae, enabling deeper dermal penetration. Studies demonstrate improved drug localization, controlled release, and enhanced therapeutic efficacy in various skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma. Applications in chemotherapy, photodynamic therapy, and immunotherapy show promising preclinical outcomes.

CONCLUSION

Despite significant advancements and encouraging preclinical results, challenges such as formulation stability, scalability, regulatory considerations, and long-term safety must be addressed before ethosomal systems can achieve successful clinical translation in skin cancer therapy.

MeSH

Skin, Cells, Pharmaceutical Preparations, Neoplasms, Drug Delivery Systems, Therapeutics, Skin Neoplasms